The current issue of JAMA Internal Medicine (2024)

Too Much Dentistry

PauloNadanovsky,DDS, PhD; Ana PaulaPires dos Santos,DDS, PhD; DavidNunan,PhD

JAMA Intern Med. 2024;184(7):713-714. doi:10.1001/jamainternmed.2024.0222

This Viewpoint explores whether all dental procedures are clinically necessary given their expense and the disparate access to treatment among some socioeconomic and racial and ethnic groups.

Health Care Reform

The Promise and Challenge of Value-Based Payment

Daniel K.Shenfeld,PhD; Amol S.Navathe,MD, PhD; Ezekiel J.Emanuel,MD, PhD

JAMA Intern Med. 2024;184(7):716-717. doi:10.1001/jamainternmed.2024.1343

This Viewpoint discusses the benefits and challenges of transitioning to a value-based payment design for health care rather than a fee-for-service system.

Time- vs Step-Based Physical Activity Metrics for Health

RikutaHamaya,MD, PhD, MS; Eric J.ShiromaJr,ScD, MEd; Christopher C.Moore,MS; et al.

JAMA Intern Med. 2024;184(7):718-725. doi:10.1001/jamainternmed.2024.0892

This cohort study compares the association of duration and intensity of physical activity with mortality and cardiovascular disease outcomes in female individuals older than 60 years.

• Editor's Note

  Tracking Physical Activity One Step at a Time

  Cary P.Gross,MD; Raegan W.Durant,MD, MPH

  JAMA Intern Med

Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial

HangyuJi,MD; XuefeiZhao,BS; XinyanChen,MD; et al.

open access

JAMA Intern Med. 2024;184(7):727-735. doi:10.1001/jamainternmed.2024.1190

This randomized clinical trial investigates whether long-term use of Jinlida granules decreases the incidence of diabetes in participants with impaired glucose tolerance and multiple metabolic abnormalities.

• Editor's Note

  Traditional Chinese Medicine to Prevent Type 2 Diabetes—A Difficult Path Forward

  Mitchell H.Katz,MD

  JAMA Intern Med

Electronic Health Record Population Health Management for Chronic Kidney Disease Care: A Cluster Randomized Clinical Trial

ManishaJhamb,MD, MPH; Melanie R.Weltman,PharmD; Susan M.Devaraj,PhD, MS, RD; et al.

open access

JAMA Intern Med. 2024;184(7):737-747. doi:10.1001/jamainternmed.2024.0708

This cluster randomized clinical trial examines the effectiveness of an electronic health record–based population health management intervention vs usual care for reducing chronic kidney disease progression.

Mobile Mindfulness Intervention for Psychological Distress Among Intensive Care Unit Survivors: A Randomized Clinical Trial

Christopher E.Cox,MD, MPH; John A.Gallis,ScM; Maren K.Olsen,PhD; et al.

JAMA Intern Med. 2024;184(7):749-759. doi:10.1001/jamainternmed.2024.0823

This randomized clinical trial evaluates the most effective method for delivering a mindfulness program via mobile app to improve depression symptoms among intensive care unit (ICU) survivors.

• Editor's Note

  Value in Optimizing the Components of App Interventions Before Final Testing

  Heather GwynnAllore,PhD; Mitchell H.Katz,MD

  JAMA Intern Med

Women's Health

Behavioral Interventions to Improve Breast Cancer Screening Outreach: Two Randomized Clinical Trials

Shivan J.Mehta,MD, MBA, MSHP; CorinneRhodes,MD, MPH; Kristin A.Linn,PhD; et al.

JAMA Intern Med. 2024;184(7):761-768. doi:10.1001/jamainternmed.2024.0495

This report of 2 randomized clinical trials evaluates whether bulk ordering, text messaging, and clinician endorsem*nt increase breast cancer screening rates.

Less Is More

Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime

RishiChanderraj,MD, MSc; Andrew J.Admon,MD, MSc, MPH; YingHe,PhD; et al.

JAMA Intern Med. 2024;184(7):769-777. doi:10.1001/jamainternmed.2024.0581

This cohort study compares 90-day mortality in patients with sepsis who received piperacillin-tazobactam vs cefepime for treatment of sepsis.

Thick Liquids and Clinical Outcomes in Hospitalized Patients With Alzheimer Disease and Related Dementias and Dysphagia

AlexanderMakhnevich,MD; AlexandraPerrin,BA; DristiTalukder,BS; et al.

JAMA Intern Med. 2024;184(7):778-785. doi:10.1001/jamainternmed.2024.0736

This cohort study assesses whether thick liquids are associated with better clinical outcomes than thin liquids in hospitalized patients with Alzheimer disease and related dementias (ADRD) and oropharyngeal dysphagia.

Household Water Lead and Hematologic Toxic Effects in Chronic Kidney Disease

JohnDanziger,MD, MPhil; JoannaWilletts,MS; JohnLarkin,PhD; et al.

JAMA Intern Med. 2024;184(7):788-796. doi:10.1001/jamainternmed.2024.0904

This cross-sectional study examines the levels of lead in household drinking water of individuals with kidney failure.

Clinical Outcomes After Admission of Patients With COVID-19 to Skilled Nursing Facilities

Brian E.McGarry,PT, PhD; Ashvin D.Gandhi,PhD; Mah AfrozeChughtai,MS; et al.

JAMA Intern Med. 2024;184(7):799-808. doi:10.1001/jamainternmed.2024.1079

This cohort study evaluates the changes in COVID-19 case counts and death rates among residents of skilled nursing facilities (SNFs) weeks before and weeks after their facility accepted hospital-discharged patients who still had COVID-19.

Patent Portfolios Protecting 10 Top-Selling Prescription Drugs

CarolineHorrow,JD; Sarah M.E.Gabriele,JD, LLM, MBE; S. SeanTu,PhD, JD; et al.

JAMA Intern Med. 2024;184(7):810-817. doi:10.1001/jamainternmed.2024.0836

This cross-sectional study examines the composition of the patents protecting the 10 top-selling prescription drugs in the US.

Reflections on Clinical Decision-Making in Contemporary Dental Practice

YehudaZadik,DMD, MHA

JAMA Intern Med. 2024;184(7):714-715. doi:10.1001/jamainternmed.2024.0291

Integrating Specialist and Primary Care in Chronic Disease Management

YasamanYazdani,MD; Amit X.Garg,MD, PhD; MerrickZwarenstein,MBBCH, PhD

JAMA Intern Med. 2024;184(7):747-748. doi:10.1001/jamainternmed.2024.0873

Less Is More

Thinning Evidence for Thickened Liquid Diets in Dementia and Dysphagia

EricWidera,MD

JAMA Intern Med. 2024;184(7):786-787. doi:10.1001/jamainternmed.2024.0733

Drinking Water of Patients With Chronic Kidney Disease—Get the Lead Out

Alexandra L.Polasko,PhD, MSc; Chi-yuanHsu,MD, MSc; MayChien,MD

JAMA Intern Med. 2024;184(7):797-798. doi:10.1001/jamainternmed.2024.0901

COVID-19 in Nursing Homes—Learning the Hard Way

James S.Goodwin,MD; HuiwenXu,PhD

JAMA Intern Med. 2024;184(7):808-809. doi:10.1001/jamainternmed.2024.1087

Tracking Physical Activity One Step at a Time

Cary P.Gross,MD; Raegan W.Durant,MD, MPH

JAMA Intern Med. 2024;184(7):726. doi:10.1001/jamainternmed.2024.0898

Traditional Chinese Medicine to Prevent Type 2 Diabetes—A Difficult Path Forward

Mitchell H.Katz,MD

JAMA Intern Med. 2024;184(7):736. doi:10.1001/jamainternmed.2024.1208

Value in Optimizing the Components of App Interventions Before Final Testing

Heather GwynnAllore,PhD; Mitchell H.Katz,MD

JAMA Intern Med. 2024;184(7):760. doi:10.1001/jamainternmed.2024.0833

Endocrine Adverse Effects of Long-Term Opioid Use

OrlyBogler,MD; Michael A.Incze,MD, MSEd

JAMA Intern Med. 2024;184(7):831-832. doi:10.1001/jamainternmed.2024.0863

Adverse Consequences of Legalization of Edible Cannabis in Older Adults

LonaMody,MD, MSc; Sharon K.Inouye,MD, MPH

JAMA Intern Med. 2024;184(7):842-843. doi:10.1001/jamainternmed.2024.1337

Health Care Expenses and Household Resources for Families With Low Income

Mitchell H.Katz,MD; Raegan W.Durant,MD, MPH; DeborahGrady,MD, MPH

JAMA Intern Med. 2024;184(7):845-846. doi:10.1001/jamainternmed.2024.1473

Approach to Obesity Treatment in Primary Care: A Review

Susan Z.Yanovski,MD; Jack A.Yanovski,MD, PhD

has active quiz has audio

JAMA Intern Med. 2024;184(7):818-829. doi:10.1001/jamainternmed.2023.8526

This review provides guidance on the treatment of obesity in adults, including lifestyle interventions, antiobesity medications, and surgical approaches.

• Audio: Pragmatic Implementation of Online Obesity Treatment and Maintenance Interventions in Primary Care

Opioid-Induced Adrenal Insufficiency

DouglasRice,MD, PhD; HirofumiYoshida,MD

has active quiz

JAMA Intern Med. 2024;184(7):830-831. doi:10.1001/jamainternmed.2024.0687

This case report describes a woman in her 40s with opioid use disorder receiving methadone who was admitted for extended antibiotic treatment for methicillin-resistant Staphylococcus aureus bacteremia and was subesequently diagnosed with opioid-induced adrenal insufficiency.

• Editor's Note

  Endocrine Adverse Effects of Long-Term Opioid Use

  OrlyBogler,MD; Michael A.Incze,MD, MSEd

  JAMA Intern Med

Less Is More

A Case for Regularly Obtaining Nutrition History: Food for Thought

MargaretShyu,MD; AnnaPfenniger,MD, PhD; Neil J.Stone,MD

has active quiz

JAMA Intern Med. 2024;184(7):832-833. doi:10.1001/jamainternmed.2024.1363

This Teachable Moment discusses providing patients with an opportunity to initiate dietary change before prescribing statin therapy for even severely high low-density lipoprotein cholesterol levels.

Anti-Asian Hate and the Health of Older Asian Individuals

LingshengLi,MD, MHS; JasmineKang,MPH; MaxwellHo,BA; et al.

JAMA Intern Med. 2024;184(7):838-840. doi:10.1001/jamainternmed.2024.1090

This qualitative study assesses the association of anti-Asian hate with older Asian individuals’ health and the clinician’s role in addressing hate incidents.

Edible Cannabis Legalization and Cannabis Poisonings in Older Adults

Nathan M.Stall,MD, PhD; ShengliShi,MD, MSc, MPH, PhD; KamilMalikov,MD, MSc, MBA; et al.

open access

JAMA Intern Med. 2024;184(7):840-842. doi:10.1001/jamainternmed.2024.1331

This cross-sectional study examines the association between edible cannabis legalization and emergency department visits for cannabis poisonings in older adults.

• Editor's Note

  Adverse Consequences of Legalization of Edible Cannabis in Older Adults

  LonaMody,MD, MSc; Sharon K.Inouye,MD, MPH

  JAMA Intern Med

Health and the 2024 US Election

Financial Burden of Health Care in the Privately Insured US Population

Sukruth A.Shashikumar,MD; ZhaoNianZheng,MSc; Karen E.Joynt Maddox,MD, MPH; et al.

JAMA Intern Med. 2024;184(7):843-845. doi:10.1001/jamainternmed.2024.1464

This cross-sectional study examines how changes in privately insured families’ contributions to insurance premiums and out-of-pocket spending have affected the financial burden of health care in recent decades.

• Editor's Note

  Health Care Expenses and Household Resources for Families With Low Income

  Mitchell H.Katz,MD; Raegan W.Durant,MD, MPH; DeborahGrady,MD, MPH

  JAMA Intern Med

Doubly Robust Causal Modeling to Evaluate Device Implantation

MichelleShardell,PhD; ChixiangChen,PhD; Rozalina G.McCoy,MD, MS

JAMA Intern Med. 2024;184(7):834-835. doi:10.1001/jamainternmed.2024.1181

This Guide to Statistics and Methods explains doubly robust causal modeling, which offers 2 opportunities to correctly model confounders, when to use it, and discusses its limitations.

A Small Wave Missed in Wide Complex Tachycardia

YiLi,MD; TongLiu,MD, PhD; ZhibingLu,MD, PhD

has active quiz

JAMA Intern Med. 2024;184(7):836-837. doi:10.1001/jamainternmed.2023.7883

This case report describes a patient in their 60s with intermittent palpitation, weakness, and irregular cardiac rhythm.

What Should I Know About Injectable Weight-Loss Medications?

AndrewKraftson,MD; DinaGriauzde,MD

free access

JAMA Intern Med. 2024;184(7):854. doi:10.1001/jamainternmed.2023.7268

This JAMA Internal Medicine Patient Page describes how to use injectable weight-loss medications as well as their risks and benefits.

Examining Safer Opioid Supply Policies

BohdanNosyk,PhD; AmandaSlaunwhite,PhD; KarenUrbanoski,PhD

JAMA Intern Med. 2024;184(7):846. doi:10.1001/jamainternmed.2024.1211

Examining Safer Opioid Supply Policies

Owen J.Chen,MSc; XiZhang,MSc; Julia X. X.Luo,MSc

JAMA Intern Med. 2024;184(7):846-847. doi:10.1001/jamainternmed.2024.1214

Examining Safer Opioid Supply Policies

HudsonReddon,PhD; PaxtonBach,MD; M-J.Milloy,PhD

JAMA Intern Med. 2024;184(7):847-848. doi:10.1001/jamainternmed.2024.1217

Examining Safer Opioid Supply Policies—Reply

Hai V.Nguyen,PhD; ShwetaMital,PhD; EmmaMcGinty,PhD

JAMA Intern Med. 2024;184(7):848. doi:10.1001/jamainternmed.2024.1220

Is Screening for Primary Aldosteronism Always the Best Option?

RomainBoulestreau,MD; ThierryCouffinhal,MD, PhD

JAMA Intern Med. 2024;184(7):849. doi:10.1001/jamainternmed.2024.1452

Is Screening for Primary Aldosteronism Always the Best Option?—Reply

Adina F.Turcu,MD, MS; SuranutCharoensri,MD; LindaBashaw,PhD

JAMA Intern Med. 2024;184(7):849-850. doi:10.1001/jamainternmed.2024.1455

Health Technology Assessment in the US—A Word of Caution

FranciscoOlivença,MPharm; Alexander I. G.Moore,MSc; Sreeram V.Ramagopalan,PhD

JAMA Intern Med. 2024;184(7):850-851. doi:10.1001/jamainternmed.2024.1458

Health Technology Assessment in the US—A Word of Caution—Reply

Olivier J.Wouters,PhD; HuseyinNaci,PhD; IrenePapanicolas,PhD

JAMA Intern Med. 2024;184(7):851. doi:10.1001/jamainternmed.2024.1461

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice

Po-RenHsiao,MD; James Cheng-ChungWei,MD, PhD

JAMA Intern Med. 2024;184(7):851-852. doi:10.1001/jamainternmed.2024.1738

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice—Reply

Julie M.Paik,MD, ScD, MPH; ElisabettaPatorno,MD, DrPH

JAMA Intern Med. 2024;184(7):852-853. doi:10.1001/jamainternmed.2024.1741

JAMA Internal Medicine

free access

JAMA Intern Med. 2024;184(7):712. doi:10.1001/jamainternmed.2023.5572